Assessment and management of disability in chronic daily headache

Current Pain and Headache Reports

Volumn 9, Issue 1, 2005, Pages 53-58

  Pryse Phillips, William ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIMIGRAINE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BUTALBITAL; CAFFEINE; CLONIDINE; CODEINE; DIHYDROERGOTAMINE; DOMPERIDONE; DOPAMINE TRANSPORTER; ERGOTAMINE TARTRATE; LIDOCAINE; METOCLOPRAMIDE; METOPROLOL; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; PARACETAMOL; PLACEBO; PREDNISONE; STEROID; TIZANIDINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID;

ACUPUNCTURE; ANXIETY; BEHAVIOR THERAPY; CHRONIC DAILY HEADACHE; CLINICAL FEATURE; COGNITIVE THERAPY; DEPRESSION; DIET THERAPY; DISABILITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG INDUCED HEADACHE; DRUG UTILIZATION; DRUG WITHDRAWAL; EXERCISE; FAMILY LIFE; FATIGUE; FEEDBACK SYSTEM; HUMAN; HYPNOSIS; LEISURE; LIFESTYLE; MEDICAL ASSESSMENT; MENTAL DISEASE; MIGRAINE; PATHOGENESIS; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PERSONALITY DISORDER; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RATING SCALE; RELAXATION TRAINING; REVIEW; SCHOOL; SOCIAL ASPECT; SYMPTOM; TENSION HEADACHE; TREATMENT OUTCOME; CHRONIC DISEASE; DISABLED PERSON; HEADACHE; PATHOPHYSIOLOGY;

CHRONIC DISEASE; DISABLED PERSONS; HEADACHE; HUMANS; PROGNOSIS;

EID: 14044253506     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-005-0075-7     Document Type: Review

References (53)

1. Gladstone J, Eross E, Dodick DW: Chronic daily headache: a rational approach to a challenging problem. Semin Neurol 2003, 23:265-276.
2. Chakravarty A: Chronic daily headaches: clinical profile in Indian patients. Cephalalgia 2003, 23:348-353.
3. Dowson A: Analysis of the patients attending a specialist UK headache clinic over a 3-year period. Headache 2003, 43: 4-18.
4. Krymchantowski AV: Primary headache diagnosis among chronic daily headache patients. Arq Neuropsiquiatr 2003, 61: 64-367.
5. Lanteri-Minet M, Auray JP, El Hasnaoui A, et al.: Prevalence and description of chronic daily headache in the general population in France. Pain 2003, 102:143-149.
6. Flippen CC: Pearls and pitfalls of headaches. Semin Neurol 2001, 21:371-376.
7. Beghi E, Monticelli ML, Amoruso L, et al.: Prevalence, characteristics, and patterns of health care use for chronic headaches in two areas of Italy: results of a questionnaire interview in general practice. Cephalalgia 2003, 23:175-182.
8. Diener FIC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet 2004, 3:475-483.
9. Lu SR, Fuh JL, Chen WT, et al.: Chronic daily headache in Taipei, Taiwan: prevalence, follow-up, and outcome predictors Cephalalgia 2001, 21:980-986.
10. Colas R, Munoz P, Temprano R, et al.: Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004, 62:1338-1342.
11. Scher AI, Stewart WF, Ricci JA, Lipton RB: Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003, 106:81-89.
12. Hershey AD: Chronic daily headaches in children. Expert Opin Pharmacother 2003, 4:485-491.
13. Esposito SB, Gherpelli JL: Chronic daily headaches in children and adolescents: a study of clinical characteristics. Cephalalgia 2004, 24:476-482.
14. Gladstein J: Children and adolescents with chronic daily headache. Curr Pain Headache Rep 2004, 8:71-75.
15. Gordon KE, Dooley JM, Wood EP: Self-reported headache frequency and features associated with frequent headaches in Canadian young adolescents. Headache 2004, 44:555-561.
16. Silberstein S, Lipton R, Nalessio D: Wolff's Headache and Other Head Pain, edn 7. Oxford: Oxford University Press; 2001.
17. Relja G, Granato M, Maria Antonella R, Zorzon M: Headache induced by chronic substance use: analysis of medication overused and minimum dose required to induce headache. Headache 2004, 6: 80.
18. Silberstein SD, Lipton RB, Sliwinski M: Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996, 47:871-875.
19. Olesen J, Bousser MG, Diener HC, et al.: The International Classification of Headache Disorders, edn 2. Cephalalgia 2004, 24:S1-S160.
20. Levin M: Chronic daily headache and the revised international headache society classification. Curr Pain Headache Rep 2004, 8:59-65.
21. Stewart WF, Lipton RB, Whyte J, et al.: An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 1999, 53:988-994.
22. Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW: Henry Ford Hospital Headache Disability Inventory. Neurology 1994, 44:837-842.
23. Ware JE: SF-36 Health Survey Manual and Interpretation Guide: 1. Boston: The Health Institute, New England Medical Centers Hospitals Inc; 2004.
24. Wagner TH, Patrick DL, Galer BS: A new instrument to assess the long-term quality of life effects from migraine: development and psychometric testing of the MSQOL. Headache 1996, 36: 84-492.
25. Jhingran P, Osterhaus JT, Miller DW, et al.: Development and validation of the Migraine-specific Quality of Life Questionnaire. Headache 1998, 38:295-302.
26. Hartmaier SL, Santanello NC, Epstein RS, et al.: Development of a brief 24-hour migraine-specific quality-of-life questionnaire. Headache 1995, 35:320-329.
27. Montagna P, Cevoli S, Marzocchi N, et al.: The genetics of chronic headaches. Neurol Sci 2003, 24: 51-S56.
28. Gallai V, Alberti A, Gallai B, et al.: Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia 2003, 23:166-174.
29. Bahra A, Walsh M, Menon S, Goadsby PJ: Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003, 43:179-190.
30. Bigal ME, Rapoport AM, Sheftell FD, et al.: Transformed migraine and medication overuse in a tertiary headache centre: clinical characteristics and treatment outcomes. Cephalalgia 2004, 24:483-490.
31. Peres MF, Zuckerman E, Young WB, Silberstein SD: Fatigue in chronic migraine patients. Cephalalgia 2002, 22: 20-724.
32. Atasoy HT, Atasoy N, Unal AE, et al.: Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain 2004, in press.
33. D'Amico D, Usai S, Grazzi L, et al.: Quality of life and disability in primary chronic headaches. Neurol Sci 2003, 24:S97-S100.
34. Bigal ME, Rapoport AM, Lipton RB, et al.: Assessment of migraine disability using the Migraine Disability Assessment (MIDAS) Questionnaire: a comparison of chronic migraine with episodic migraine Headache 2003, 43:336-342.
35. Duru G, Auray JP, Gaudin AF, et al.: Impact of headache on quality of life in a general population survey in France (GRIM2000 Study). Headache 2004, 44:571-580.
36. Guitera V, Munoz P, Castillo J, Pascual J: Quality of life in chronic daily headache: a study in a general population. Neurology 2002, 58:1062-1065.
37. Monzon MJ, Lainez MJ: Quality of life in migraine and chronic daily headache patients. Cephalalgia 1998, 18: 38-643.
38. Wang SJ, Fuh JL, Lu SR, Juang KD: Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. Pain 2001, 89:285-292.
39. Meletiche DM, Lofland JH, Young WB: Quality-of-life differences between patients with episodic and transformed migraine. Headache 2001, 41:573-578.
40. Cassidy EM, Tomkins E, Hardiman O, O'Keane V: Factors associated with burden of primary headache in a specialty clinic. Headache 2003, 43:638-644.
41. Bigal ME, Sheftell FD, Rapoport AM, et al.: Chronic daily headache: identification of factors associated with induction and transformation. Headache 2002, 42:575-581.
42. Harpole LH, Samsa GP, Jurgelski AE, et al.: Headache management program improves outcome for chronic headache. Headache 2003, 43:715-724.
43. Magnusson JE, Reis CM, Becker WJ: Effectiveness of a multidisciplinary treatment program for chronic daily headache. Can J Neurol Sci 2004, 31:72-79.
44. Williams DR, Stark RJ: Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003, 23:963-971.
45. Krymchantowski AV, Moreira PF: Outpatient detoxification in chronic migraine. Cephalalgia 2003, 23:982-993.
46. Ondo WG, Vuong KD, Derman HS: Botulinum toxin A for chronic daily headache: a randomised, placebo-controlled parallel design study. Cephalalgia 2004, 24:60-65.
47. Padberg M, de Bruijn SF, de Haan RJ, Tavy DL: Treatment of chronic tension tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia 2004, 24:675-680.
48. Green SH: Chronic and recurrent headache. Curr Pediatr 2002, 12:186-190.
49. Grazzi L, Usai S, Bussone G: Chronic headache in young patients: clinical aspects and treatment suggestions. Neurol Sci 2003, 24(suppl 2):S112-S114.
50. Fritsche G, Diener HC: Medication overuse headaches: What is new? Exp Opin Drug Safety 2002, 1:331-338.
51. Schnider P, Aull S, Baumgartner C, et al.: Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: 5-year follow-up. Cephalalgia 1996, 16: 81-485.
52. Linton-Dahlof P, Linde M, Dahlof C: Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000, 20:658-662.
53. Pini LA, Cicero AF, Sandrini M: Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001, 21:878-883.